BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35034926)

  • 1. CASC5 is a potential cancer-testis gene in human urinary bladder transitional cell carcinoma.
    Singh PK; Bhatt MLB; Singh P; Rath SK; Dalela D; Goel MM
    Drug Discov Ther; 2021; 15(6):331-336. PubMed ID: 35034926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent expression of a novel cancer testis antigen, protein kinase human monopolar spindle 1 (hMps1/TTK) in human urinary bladder transitional cell carcinoma.
    Singh PK; Bhatt MLB; Singh P; Rath SK; Dalela D; Goel MM
    Drug Discov Ther; 2021 Sep; 15(4):204-209. PubMed ID: 34456216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma.
    Singh PK; Srivastava AK; Rath SK; Dalela D; Goel MM; Bhatt ML
    Immunobiology; 2015 Jan; 220(1):103-8. PubMed ID: 25178936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma.
    Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
    Immunobiology; 2015 Jan; 220(1):68-73. PubMed ID: 25214475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive diagnostic potential of microRNA-203 in liquid biopsy of urothelial carcinoma of bladder.
    Singh P; Singh A; Gupta N; Raja KD; Singh P; Agarwal S; Sharma A
    Mol Cell Biochem; 2022 Sep; 477(9):2173-2182. PubMed ID: 35445913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer.
    Wang K; Liu T; Liu C; Meng Y; Yuan X; Liu L; Ge N; Liu J; Wang C; Ren H; Yan K; Hu S; Xu Z; Fan Y; Xu D
    Oncologist; 2015 Mar; 20(3):263-9. PubMed ID: 25657201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma.
    Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
    Immunobiology; 2014 Jun; 219(6):469-74. PubMed ID: 24629784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IIICS de novo glycosylated fibronectin as a marker for invasiveness in urothelial carcinoma of the urinary bladder (UBC).
    Richter P; Junker K; Franz M; Berndt A; Geyer C; Gajda M; Kosmehl H; Berndt A; Wunderlich H
    J Cancer Res Clin Oncol; 2008 Oct; 134(10):1059-65. PubMed ID: 18386055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of molecular signatures in the urinary bladder and upper tract urothelial carcinomas: a prospective controlled clinical study.
    Dawood EE; Awadalla A; Hashem A; Shokeir AA; Abdel-Aziz AF
    J Egypt Natl Canc Inst; 2022 Nov; 34(1):47. PubMed ID: 36372809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of urinary bladder cancer antigen as a marker for diagnosis of transitional cell carcinoma of the urinary bladder.
    Heicappell R; Schostak M; Müller M; Miller K
    Scand J Clin Lab Invest; 2000 Jul; 60(4):275-82. PubMed ID: 10943597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-Testis Antigens as New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of Bladder.
    Afsharpad M; Nowroozi MR; Mobasheri MB; Ayati M; Nekoohesh L; Saffari M; Zendehdel K; Modarressi MH
    Pathol Oncol Res; 2019 Jan; 25(1):191-199. PubMed ID: 29058301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients.
    Liu X; Yao D; Liu C; Cao Y; Yang Q; Sun Z; Liu D
    Tumour Biol; 2016 Jun; 37(6):8367-74. PubMed ID: 26733163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
    Amara N; Palapattu GS; Schrage M; Gu Z; Thomas GV; Dorey F; Said J; Reiter RE
    Cancer Res; 2001 Jun; 61(12):4660-5. PubMed ID: 11406532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of cancer-testis genes in transitional cell carcinoma of the bladder.
    Yin B; Liu G; Wang XS; Zhang H; Song YS; Wu B
    Urol Oncol; 2012; 30(6):886-92. PubMed ID: 21396841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBC
    Ecke TH; Weiß S; Stephan C; Hallmann S; Barski D; Otto T; Gerullis H
    Tumour Biol; 2017 May; 39(5):1010428317701624. PubMed ID: 28468590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testis expressed 19 is a novel cancer-testis antigen expressed in bladder cancer.
    Zhong J; Chen Y; Liao X; Li J; Wang H; Wu C; Zou X; Yang G; Shi J; Luo L; Liu L; Deng J; Tang A
    Tumour Biol; 2016 Jun; 37(6):7757-65. PubMed ID: 26695143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder.
    Lee DH; Yoon H; Park S; Kim JS; Ahn YH; Kwon K; Lee D; Kim KH
    Sci Rep; 2018 Oct; 8(1):14707. PubMed ID: 30279572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette smoking extract causes hypermethylation and inactivation of WWOX gene in T-24 human bladder cancer cells.
    Yang W; Cui S; Ma J; Lu Q; Kong C; Liu T; Sun Z
    Neoplasma; 2012; 59(2):216-23. PubMed ID: 22248280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative and quantitative detection of urinary human complement factor H-related protein (BTA stat and BTA TRAK) and fragments of cytokeratins 8, 18 (UBC rapid and UBC IRMA) as markers for transitional cell carcinoma of the bladder.
    Babjuk M; Kostírová M; Mudra K; Pecher S; Smolová H; Pecen L; Ibrahim Z; Dvorácek J; Jarolím L; Novák J; Zima T
    Eur Urol; 2002 Jan; 41(1):34-9. PubMed ID: 11999463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [One-stage transurethral resection of the urinary bladder and the prostate in patients with superficial cancer of the urinary bladder combined with benign prostatic hyperplasia].
    Karaguzhin SG; Merinov DS; Martov AG
    Urologiia; 2005; (5):17-21. PubMed ID: 16281833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.